November 21, 2012

A*STAR Scientists Identify Potential Drug Target For Inflammatory Diseases Including Cancers

This discovery holds the potential to reduce healthcare costs for many common inflammatory diseases such as cancer and diabetes

1.       A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune disorders, neurodegenerative diseases, and metabolic diseases such as diabetes. This enzyme, which is known to be responsible for providing cancer cells the endless ability to divide, is now found to also jumpstart and maintain chronic inflammation in cancers.